Sort
130,381 grants matching “hiv”
Administrative Core
$944,290Richard E Chaisson · Johns Hopkins University · P30 · FY2013 · AI
EPIDEMIOLOGY OF HUMAN RETROVIRUSES IN BLOOD DONORS
$944,284American National Red Cross Los Angeles · N01 · FY2000 · HB
Structure-Based Design of Drugs for Target
$944,198Rutgers The St Univ Of Nj New Brunswick · P01 · FY2002 · GM
2/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial
$944,023Catherine A Spino · University Of Michigan At Ann Arbor · U24 · FY2024 · HL
Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies
$943,932Laurent Karl Verkoczy · San Diego Biomedical Research Institute · R01 · FY2019 · AI
Delaware Valley Node of the Clinical Trials Network
$943,791George E Woody · University Of Pennsylvania · U10 · FY2013 · DA
Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease
$943,730Sulggi Angela Lee · University Of California, San Francisco · R61 · FY2021 · DA
A Novel, Logical Approach to HIV Vaccine Development
$943,623David I Watkins · University Of Wisconsin-Madison · R01 · FY2008 · AI
Structural studies of native-like SOSIP trimers
$943,450Ian A Wilson · Weill Medical Coll Of Cornell Univ · P01 · FY2019 · AI
Therapeutic Strategies for the Management of HCV/HIV co- infection
$943,367Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Therapeutic Use of an Enhanced Form of CD4-Ig
$943,250Michael R. Farzan · Scripps Florida · R37 · FY2018 · AI
PANDAA for universal, pan-lineage molecular detection of filoviruses to enable rapid epidemic response.
$943,229Iain James Macleod · Aldatu Biosciences, Inc. · R44 · FY2024 · AI
Global Analysis of Cellular Networks Involved In Restriction of HIV Replication
$943,141Sumit K Chanda · Salk Institute For Biological Studies · P01 · FY2012 · AI
Training in Biomedical Informatics at Columbia University
$943,020Noemie Elhadad · Columbia University Health Sciences · T15 · FY2024 · LM
ED2PrEP - patient focused, low-burden strategies for PrEP uptake among emergency departments patients: a cross-over hybrid implementation-effectiveness trial
$942,998Uriel Felsen · Albert Einstein College Of Medicine · R01 · FY2024 · AI
Preclinical Development of Ad26/Env Vaccines for HIV
$942,991Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2022 · AI
Clinical Core
$942,872Frederick M Hecht · University Of California, San Francisco · P01 · FY2008 · AI
Strategies for targeting T follicular helper cells to improve HIV Env vaccine immunogenicity and efficacy
$942,815Ellen Elizabeth Sparger · University Of California At Davis · P01 · FY2025 · AI
Role of microRNAs in B-cell dysfunction in HIV/SIV infection
$942,811Mahesh Mohan · Texas Biomedical Research Institute · R01 · FY2020 · DA
Innate Immunity and HIV Restriction
$942,806John C Reed · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2014 · AI
HIV-Receptor Interactions and Related Anti-HIV Strategies
$942,587Edward Berger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Broad spectrum therapeutics targeting resolvase enzymes
$942,460Frederic D Bushman · University Of Pennsylvania · U01 · FY2010 · AI
Coordinating Center for the Pediatric HIV/AIDS Cohort Study II
$942,396Russell Barrett Van Dyke · Tulane University Of Louisiana · U01 · FY2013 · HD
A nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention (EXTRA-CVD)
$942,293Chris Todd Longenecker · Case Western Reserve University · U01 · FY2020 · HL
DISSEMINATED TUBERCULOSIS IN HIV INFECTION
$942,272Dartmouth College · R01 · FY2003 · AI